Resmed Inc. buy Mizuho
Start price
13.04.23
/
50%
€203.30
Target price
13.04.24
-
Performance (%)
-13.63%
End price
14.04.24
€175.60
Summary
This prediction ended on 14.04.24 with a price of €175.60. The prediction for Resmed Inc. disappointed with a performance of -13.63%. Mizuho has a follow-up prediction for Resmed Inc. where he still thinks Resmed Inc. is a Buy. Dividends of €1.73 are taken into consideration when calculating the performance. Mizuho has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Resmed Inc. | -0.666% | -0.666% | 3.525% | -5.989% |
| iShares Core DAX® | 3.593% | 3.931% | 15.378% | 53.202% |
| iShares Nasdaq 100 | 5.810% | 5.518% | 41.455% | 91.095% |
| iShares Nikkei 225® | 4.075% | 8.460% | 48.947% | 63.933% |
| iShares S&P 500 | 4.142% | 4.039% | 31.594% | 64.840% |
Comments by Mizuho for this prediction
In the thread Resmed Inc. diskutieren
ResMed Inc. (NYSE: RMD) is now covered by analysts at Mizuho. They set a "buy" rating on the stock.
Ratings data for RMD provided by MarketBeat
In the thread Trading Resmed Inc.
Die von Mizuho gewählte maximale Laufzeit wurde überschritten